ERSTE Stock Biotec D01 T
AT0000A1YFD1
ERSTE Stock Biotec D01 T/ AT0000A1YFD1 /
| NAV04/11/2024 |
Diferencia+1.0100 |
Tipo de beneficio |
Enfoque de la inversión |
Sociedad de fondos |
| 124.7400EUR |
+0.82% |
reinvestment |
Equity
Sector Biotechnology
|
Erste AM ▶ |
Objetivo de inversión
The ESPA STOCK BIOTEC fund invests in the most important biotech companies, primarily those in the USA. Equities from the Pacific region and Europe play a minor role, but are also selectively added to the fund. The currencies are not hedged against the euro. The fund is particularly suitable as an addition to an existing equity portfolio and is geared towards achieving long-term capital appreciation.
Datos maestros
| Tipo de beneficio: |
reinvestment |
| Categoría de fondos: |
Equity |
| País: |
United States of America |
| Sucursal: |
Sector Biotechnology |
| Punto de referencia: |
Solactive United States Biotechnology Index NTR |
| Inicio del año fiscal: |
15/03 |
| Última distribución: |
- |
| Banco depositario: |
Erste Group Bank AG |
| País de origen: |
Austria |
| Permiso de distribución: |
Austria, Germany, Czech Republic |
| Gestor de fondo: |
Harald Kober, Tamas Menyhart |
| Volumen de fondo: |
226.97 millones
EUR
|
| Fecha de fundación: |
22/12/2017 |
| Enfoque de la inversión: |
- |
Condiciones
| Recargo de emisión: |
4.00% |
| Max. Comisión de administración: |
1.14% |
| Inversión mínima: |
0.00 EUR |
| Deposit fees: |
- |
| Cargo por amortización: |
0.00% |
| Prospecto simplificado: |
Descargar (Versión para imprimir) |
Sociedad de fondos
| Fondos de empresa: |
Erste AM |
| Dirección: |
Am Belvedere 1, 1100, Wien |
| País: |
Austria |
| Internet: |
www.erste-am.at
|
Países
| United States of America |
|
78.89% |
| United Kingdom |
|
9.10% |
| Netherlands |
|
3.92% |
| China |
|
1.96% |
| Denmark |
|
1.19% |
| Virgin Islands (British) |
|
1.06% |
| Bermuda |
|
1.00% |
| Canada |
|
0.85% |
| Ireland |
|
0.69% |
| Cash |
|
0.45% |
| Singapore |
|
0.34% |
| Cayman Islands |
|
0.30% |
| Belgium |
|
0.17% |
| Spain |
|
0.08% |
Sucursales
| Pharma/Biotechnology |
|
96.10% |
| Healthcare services |
|
3.44% |
| Cash |
|
0.45% |
| Otros |
|
0.01% |
